First Wave BioPharma (NASDAQ:FWBI) on Track to Release Top-Line Data in July for Digestive Disorder in Cystic Fibrosis

First Wave BioPharma, Inc. (NASDAQ:FWBI) shares rocket 169% as the company announced the enrollment target for its ongoing Phase 2

Related Keywords

United States ,India ,Paxlovid Lagevrio ,Angela Hwang ,Pfizer ,Atea Pharmaceuticals ,Bioxytran Inc ,Nuclear Magnetic Resonance ,Fierce Pharma ,